Biotechnology Biotech Pharmaceutical
LifeRaft Biosciences is a Philadelphia-based biotechnology company focused on developing innovative therapies that repair damaged cell membranes and reduce tissue injury. Its lead drug candidate, Vepoloxamer, is being developed to prevent severe oral mucositis caused by radiation therapy in head and neck cancer patients. The company is also exploring treatments for acute burns and other injuries involving cellular damage, aiming to improve patient outcomes through advanced membrane-repair technology.